chr1-167435434-G-A

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_198053.3(CD247):​c.301C>T​(p.Gln101*) variant causes a stop gained, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000272 in 1,611,206 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00028 ( 1 hom. )

Consequence

CD247
NM_198053.3 stop_gained, splice_region

Scores

3
3
Splicing: ADA: 0.8434
1
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:6

Conservation

PhyloP100: 3.50

Publications

7 publications found
Variant links:
Genes affected
CD247 (HGNC:1677): (CD247 molecule) The protein encoded by this gene is T-cell receptor zeta, which together with T-cell receptor alpha/beta and gamma/delta heterodimers, and with CD3-gamma, -delta and -epsilon, forms the T-cell receptor-CD3 complex. The zeta chain plays an important role in coupling antigen recognition to several intracellular signal-transduction pathways. Low expression of the antigen results in impaired immune response. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CD247 Gene-Disease associations (from GenCC):
  • immunodeficiency 25
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 1-167435434-G-A is Pathogenic according to our data. Variant chr1-167435434-G-A is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 419227.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CD247NM_198053.3 linkc.301C>T p.Gln101* stop_gained, splice_region_variant Exon 5 of 8 ENST00000362089.10 NP_932170.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CD247ENST00000362089.10 linkc.301C>T p.Gln101* stop_gained, splice_region_variant Exon 5 of 8 1 NM_198053.3 ENSP00000354782.5

Frequencies

GnomAD3 genomes
AF:
0.000204
AC:
31
AN:
152184
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000323
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000263
AC:
66
AN:
250742
AF XY:
0.000251
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000647
Gnomad NFE exome
AF:
0.000353
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000280
AC:
408
AN:
1459022
Hom.:
1
Cov.:
29
AF XY:
0.000289
AC XY:
210
AN XY:
726076
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33428
American (AMR)
AF:
0.000291
AC:
13
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26116
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39676
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86194
European-Finnish (FIN)
AF:
0.000936
AC:
50
AN:
53400
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5756
European-Non Finnish (NFE)
AF:
0.000295
AC:
327
AN:
1109424
Other (OTH)
AF:
0.000282
AC:
17
AN:
60318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.434
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000204
AC:
31
AN:
152184
Hom.:
0
Cov.:
32
AF XY:
0.000215
AC XY:
16
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41434
American (AMR)
AF:
0.0000654
AC:
1
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000323
AC:
22
AN:
68040
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000228
Hom.:
0
Bravo
AF:
0.000212
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000222
AC:
27
EpiCase
AF:
0.000327
EpiControl
AF:
0.000296

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Immunodeficiency 25 Pathogenic:3
Aug 29, 2022
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 28, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Gln101*) in the CD247 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CD247 are known to be pathogenic (PMID: 17170122, 26542031). This variant is present in population databases (rs55729925, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with CD247-related conditions. ClinVar contains an entry for this variant (Variation ID: 419227). For these reasons, this variant has been classified as Pathogenic.

CD247-related disorder Pathogenic:1
Aug 22, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The CD247 c.301C>T variant is predicted to result in premature protein termination (p.Gln101*). This variant was reported in the heterozygous state, and interpreted as pathogenic, in individuals undergoing preconception carrier screening analyses (Supplementary Table 001, Capalbo et al. 2019. PubMed ID: 31589614). This variant is reported in 0.068% of alleles in individuals of European (Finnish) descent in gnomAD. Nonsense variants in CD247 are expected to be pathogenic. This variant is interpreted as likely pathogenic.

Severe combined immunodeficiency disease Pathogenic:1
Apr 30, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: CD247 c.301C>T (p.Gln101X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 0.00026 in 250742 control chromosomes in the gnomAD database, including 1 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in CD247 causing Severe Combined Immunodeficiency (0.00026 vs 0.00035), allowing no conclusion about variant significance. c.301C>T has been reported in the literature in individuals affected with Primary immunodeficiencies (examples: Gallo_2016 and Rudilla_2019). The following publications have been ascertained in the context of this evaluation (PMID: 27872624, 31681265). ClinVar contains an entry for this variant (Variation ID: 419227). Based on the evidence outlined above, the variant was classified as pathogenic.

not provided Pathogenic:1
Oct 13, 2025
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Identified heterozygous in individuals with immune system irregularities, however a second CD247 variant was not identified in these cases (PMID: 38992472); Published functional studies demonstrate a damaging effect, specifically reduced T-cell receptor expression (PMID: 38992472); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31345219, 38992472, 31589614)

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.39
D
BayesDel_noAF
Pathogenic
0.60
CADD
Pathogenic
45
DANN
Uncertain
1.0
Eigen
Pathogenic
0.87
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Uncertain
0.93
D
PhyloP100
3.5
Vest4
0.66
GERP RS
4.2
Mutation Taster
=50/150
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.84
dbscSNV1_RF
Pathogenic
0.75
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55729925; hg19: chr1-167404671; API